Investors

Our successful business model provides a solid platform for growth. We combine a diverse portfolio with excellent financial discipline to deliver outstanding value for shareholders.

Ensuring patients have access to the medicines they need is at the heart of everything we do. In 2025, we continued to invest in our people, capabilities, and infrastructure to strengthen our ability to deliver high-quality, affordable medicines across the communities we serve. 

Our resilient and diversified business model is balanced across Injectables, Branded and Hikma Rx segments, enabling us to respond to opportunities and challenges, while delivering value for our stakeholders

We aim to deliver consistent and profitable growth by putting better health within reach every day, creating high-quality medicines and making them accessible for patients around the world.

Learn more about our current and historical performance, read our reports and access our presentations.

Stay informed of key dates in our financial calendar.

Find up-to-date information including share price details, investment calculator and share price look up. 

Everything you need to manage your shares, including share listings, depositary receipts, share price information, dividends and dividend calculator. 

We are a multinational pharmaceutical company with a local presence across North America, Europe and MENA, providing customers with a broad range of generic, specialty and branded pharmaceutical products.

Stay up-to-date on our latest stories.